China A-share innovative drug sector ticked higher after volatile trading.
Shutaishen hit a 20% limit-up; Jinyao Pharmaceutical had earlier hit limit-up.
Baili Tianheng, Betta Pharmaceuticals, Jinbo Biotech, Nanjing Xinbai and
Tongrentang is also advanced.